Nasus Pharma NSRX
NYSE NSRX
$3.03 -0.21 (-6.31%)
As of: Oct 21, 2026 · 3:59 PM EDT

Nasus Pharma (NSRX) Current Assets (2024 - 2026)

Updated

Nasus Pharma (NSRX) posted Current Assets of $12.31 million for Q2 2026, compared with $291,000 a year earlier.

Analysis

Nasus Pharma (NSRX) Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Nasus Pharma's Current Assets came in at $4.86 million, up 962.4% from FY2024.

  • In prior years, Nasus Pharma's Current Assets was $457,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 64.67 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 59.77 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 33.67 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 36.68 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 27.35 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 27.97 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.96 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 13.95 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 41.36 Bn
10 Nasus Pharma 25.55 Mn 8.85 Mn - 12.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.31 Mn
Dec 31, 2025 4.86 Mn
Jun 30, 2025 291,000.00
Dec 31, 2024 457,000.00
API Access

Nasus Pharma Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=NSRX&period=max&api_key=YOUR_API_KEY